R&D Precision, speed, impact: Evolving mass spectrometry for med... MOBILion's Melissa Sherman explores the evolving role of mass spectrometry in drug discovery, complex molecule analysis, and medical research.
Partner Content Partner Content Invite from the Chairman Hugues Malonne at the Molecular Dia... Invite from the Chairman Hugues Malonne at Molecular Dx
Partner Content Partner Content This Week's Spotlight Features GSK and Advanced Cell Diagnos... RNA Therapeutics Feb 2018
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.